INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 89 filers reported holding INSMED INC in Q4 2013. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,925,909 | +23.7% | 2,531,719 | +3.4% | 0.01% | +27.3% |
| Q2 2023 | $51,662,584 | +21.5% | 2,448,464 | -1.8% | 0.01% | +22.2% |
| Q1 2023 | $42,518,001 | +57.0% | 2,493,724 | +84.0% | 0.01% | +50.0% |
| Q4 2022 | $27,080,511 | +33.5% | 1,355,381 | +43.9% | 0.01% | +20.0% |
| Q3 2022 | $20,282,000 | +105.1% | 941,582 | +87.8% | 0.01% | +150.0% |
| Q2 2022 | $9,888,000 | -16.8% | 501,421 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $11,888,000 | -13.4% | 505,869 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $13,733,000 | +1.4% | 504,152 | +2.6% | 0.00% | -33.3% |
| Q3 2021 | $13,537,000 | +7.1% | 491,516 | +10.7% | 0.00% | +50.0% |
| Q2 2021 | $12,635,000 | -11.2% | 443,958 | +6.3% | 0.00% | -33.3% |
| Q1 2021 | $14,229,000 | -1.2% | 417,743 | -3.5% | 0.00% | 0.0% |
| Q4 2020 | $14,407,000 | +2.4% | 432,763 | -1.1% | 0.00% | 0.0% |
| Q3 2020 | $14,070,000 | +13.9% | 437,787 | -2.4% | 0.00% | 0.0% |
| Q2 2020 | $12,349,000 | +90.4% | 448,434 | +10.8% | 0.00% | +50.0% |
| Q1 2020 | $6,485,000 | -32.1% | 404,613 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $9,548,000 | +41.9% | 399,869 | +4.8% | 0.00% | 0.0% |
| Q3 2019 | $6,729,000 | -32.1% | 381,444 | -1.4% | 0.00% | -33.3% |
| Q2 2019 | $9,908,000 | -10.2% | 387,003 | +2.0% | 0.00% | 0.0% |
| Q1 2019 | $11,031,000 | +127.9% | 379,451 | +2.9% | 0.00% | +50.0% |
| Q4 2018 | $4,840,000 | -34.8% | 368,929 | +0.4% | 0.00% | 0.0% |
| Q3 2018 | $7,428,000 | -15.0% | 367,322 | -0.6% | 0.00% | 0.0% |
| Q2 2018 | $8,739,000 | +1.4% | 369,483 | -3.4% | 0.00% | 0.0% |
| Q1 2018 | $8,616,000 | -34.2% | 382,583 | -9.0% | 0.00% | -33.3% |
| Q4 2017 | $13,103,000 | +0.2% | 420,220 | +0.3% | 0.00% | -25.0% |
| Q3 2017 | $13,076,000 | +130.3% | 418,949 | +26.6% | 0.00% | +100.0% |
| Q2 2017 | $5,677,000 | +3.1% | 330,873 | +5.2% | 0.00% | 0.0% |
| Q1 2017 | $5,507,000 | +37.7% | 314,494 | +4.1% | 0.00% | +100.0% |
| Q4 2016 | $3,998,000 | -6.4% | 302,158 | +2.8% | 0.00% | 0.0% |
| Q3 2016 | $4,270,000 | +50.7% | 294,040 | +2.3% | 0.00% | 0.0% |
| Q2 2016 | $2,834,000 | -21.8% | 287,391 | +0.5% | 0.00% | 0.0% |
| Q1 2016 | $3,623,000 | -27.8% | 285,994 | +3.5% | 0.00% | -50.0% |
| Q4 2015 | $5,017,000 | -1.1% | 276,393 | +1.2% | 0.00% | 0.0% |
| Q3 2015 | $5,072,000 | -37.4% | 273,080 | -17.7% | 0.00% | 0.0% |
| Q2 2015 | $8,108,000 | +46.6% | 332,006 | +24.9% | 0.00% | +100.0% |
| Q1 2015 | $5,529,000 | +42.2% | 265,821 | +5.7% | 0.00% | 0.0% |
| Q4 2014 | $3,889,000 | -5.7% | 251,377 | -20.4% | 0.00% | 0.0% |
| Q3 2014 | $4,124,000 | -61.4% | 315,985 | -40.8% | 0.00% | 0.0% |
| Q2 2014 | $10,674,000 | +121.9% | 534,194 | +111.4% | 0.00% | 0.0% |
| Q1 2014 | $4,811,000 | +32.7% | 252,665 | +18.5% | 0.00% | 0.0% |
| Q4 2013 | $3,625,000 | -46.0% | 213,223 | -50.4% | 0.00% | 0.0% |
| Q3 2013 | $6,716,000 | +233.6% | 430,184 | +155.5% | 0.00% | 0.0% |
| Q2 2013 | $2,013,000 | – | 168,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |